Note: Descriptions are shown in the official language in which they were submitted.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
1
Auto-injector
Technical Field
The invention relates to an auto-injector for administering a dose of a liquid
medicament.
Background of the Invention
Administering an injection is a process which presents a number of risks and
challenges
for users and healthcare professionals, both mental and physical.
Injection devices (i.e. devices capable of delivering medicaments from a
medication
container) typically fall into two categories ¨ manual devices and auto-
injectors.
In a manual device ¨ the user must provide the mechanical energy to drive the
fluid
through the needle. This is typically done by some form of button / plunger
that has to
be continuously pressed by the user during the injection. There are numerous
disadvantages to the user from this approach. If the user stops pressing the
button /
plunger then the injection will also stop. This means that the user can
deliver an
underdose if the device is not used properly (i.e. the plunger is not fully
pressed to its
end position). Injection forces may be too high for the user, in particular if
the patient is
elderly or has dexterity problems.
The extension of the button/plunger may be too great. Thus it can be
inconvenient for
the user to reach a fully extended button. The combination of injection force
and button
extension can cause trembling / shaking of the hand which in turn increases
discomfort
as the inserted needle moves.
Auto-injector devices aim to make self-administration of injected therapies
easier for
patients. Current therapies delivered by means of self-administered injections
include
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
2
drugs for diabetes (both insulin and newer GLP-1 class drugs), migraine,
hormone
therapies, anticoagulants etc.
Auto-injectors are devices which completely or partially replace activities
involved in
parenteral drug delivery from standard syringes. These activities may include
removal of
a protective syringe cap, insertion of a needle into a patient's skin,
injection of the
medicament, removal of the needle, shielding of the needle and preventing
reuse of the
device. This overcomes many of the disadvantages of manual devices. Injection
forces /
button extension, hand-shaking and the likelihood of delivering an incomplete
dose are
reduced. Triggering may be performed by numerous means, for example a trigger
button or the action of the needle reaching its injection depth. In some
devices the
energy to deliver the fluid is provided by a spring.
US 2002/0095120 A1 discloses an automatic injection device which automatically
injects a pre-measured quantity of fluid medicine when a tension spring is
released. The
tension spring moves an ampoule and the injection needle from a storage
position to a
deployed position when it is released. The content of the ampoule is
thereafter expelled
by the tension spring forcing a piston forward inside the ampoule. After the
fluid
medicine has been injected, torsion stored in the tension spring is released
and the
injection needle is automatically retracted back to its original storage
position.
Summary of the Invention
It is an object of the present invention to provide an improved auto-injector.
The object is achieved by an auto-injector according to claim 1.
Preferred embodiments of the invention are given in the dependent claims.
In the context of this specification, the terms distal and proximal are
defined from the
point of view of a person receiving an injection. Consequently, a proximal
direction
refers to a direction pointing towards the body of a patient receiving the
injection and a
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
3
proximal end defines an end of an element that is directed towards the body of
the
patient. Respectively, the distal end of an element or the distal direction is
directed
away from the body of the patient receiving the injection and opposite to the
proximal
end or proximal direction.
According to the invention, an auto-injector for administering a dose of a
liquid
medicament comprises
- a substantially cylindrical chassis arranged to contain a pre-filled
syringe with a syringe
barrel filled with the medicament, an injection needle and a stopper for
sealing the
syringe barrel,
- a needle shroud slidably arranged within the chassis and adapted to rest
on the skin of
a patient receiving an injection,
- a plunger adapted to translate the stopper to expel the dose of the
medicament
through the injection needle,
- a coupling shroud slidably arranged within the chassis and releasably
coupled to the
plunger and
- a drive means. Upon release, the drive means is capable of driving the
coupling
shroud from a first position in a proximal direction. The proximal translatory
movement
of the coupling shroud with respect to the chassis
- translates the pre-filled syringe in the proximal direction to expose the
injection needle,
- depresses the plunger connected to the stopper into the syringe barrel to
expel the dose of medicament and
- advances the needle shroud to a safe position to surround the injection
needle after the injection. The coupling shroud is arranged to be decoupled
from the
plunger at a second position. The needle shroud is arranged to prevent the
decoupling
of plunger and coupling shroud when the needle shroud is in a retracted
position,
whereas the needle shroud is arranged to allow for the decoupling of plunger
and
coupling shroud when the needle shroud is moved from the retracted position
towards
the safe position.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
4
A crucial step in delivering medicaments with auto-injectors is the decoupling
of the
plunger at the appropriate point in time. If the plunger is decoupled early,
the dose of
the medicament might not be completely expelled. Consequently the medicament
is
partially wasted during the injection. However, such an early release might be
necessary to ensure that the plunger is decoupled at the end of an injection
stroke, so
that in particular functions that ensure needle safety are reliably carried
out. The
injection mechanism of the auto-injector is designed in a manner that allows
for a
complete emptying of the syringe barrel containing the dose of the medicament
before
the plunger is decoupled from the coupling shroud without compromising needle
safety.
During the injection, the needle shroud of the auto-injector is pushed against
an
injection site as to move the needle shroud into the retracted position. The
needle
shroud is arranged to prevent the decoupling of the plunger from the coupling
shroud as
long as the needle shroud remains in the retracted position. When the dose of
the
medicament has been completely expelled and the auto-injector is removed from
the
injection site, the needle shroud leaves the retracted position and is moved
proximally
towards the safe position. Thus, the auto-injector according to the invention
provides a
reliable mechanism that covers the injection needle to avoid accidental needle
stick
injuries after the injection without wasting any medicament initially
contained in the pre-
filled syringe.
Preferably, the coupling shroud is initially coupled to the plunger to
translate the syringe
retainer proximally, whereby the injection needle is inserted into the skin of
the patient,
and to subsequently depress the stopper into the syringe barrel to expel the
medicament. A coupling catch of the coupling shroud abutting against a
shoulder
formed to the plunger provides a particular simple and reliable means to
releasably
couple the plunger to the coupling shroud. The coupling catch and the shoulder
is
arranged in a ramped engagement with each other as to allow for a deflection
of the
coupling catch in a radial outward direction when the coupling shroud is
translated with
respect to the plunger in the proximal direction, whereby the coupling between
the
plunger and the coupling shroud is released. A premature decoupling of the
plunger and
the coupling shroud is prevented as the coupling catch abuts against the
chassis in the
radial outward direction until the coupling shroud reaches the second
position.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
According to a possible embodiment of the invention, the decoupling of the
plunger and
the coupling shroud takes place at the second position that is located in a
manner, so
that the needle shroud may be advanced by the decoupled coupling shroud that
is
5 biased by the drive means after the stopper has bottomed out and the
medication has
been completely delivered. The second position is defined by an aperture in
the chassis.
The aperture formed into the chassis at the second position allows the
coupling catch to
deflect radially outwards at the second position, so that the coupling shroud
is
decoupled from the plunger after the medicament is completely delivered and
the auto
injector is removed from the injection site.
Preferably, the needle shroud comprises an intermediate section that is
slidably
retained within the aperture formed into the chassis. When the needle shroud
is located
in the retracted position, the intermediate section of the needle shroud abuts
against the
coupling catch in the radial direction. Thus the decoupling of the plunger
from the
coupling shroud is prevented until the needle shroud leaves the retracted
position. As
the auto-injector is pushed against the skin of the patient during the
injection to retain
the needle shroud in the retracted position, the needle shroud cannot leave
the
retracted position until the auto-injector is removed from the injection site.
Thus, the
decoupling is delayed until the dose of the medication contained in the pre-
filled syringe
is completely expelled and the auto-injector is removed from the injection
site before the
needle safety features of the auto-injector are activated.
According to another possible embodiment of the invention, a syringe retainer
is slidably
arranged with respect to the chassis. The syringe retainer receives and mounts
the pre-
filled syringe to the chassis of the auto-injector, wherein initially the
syringe retainer is
releasably affixed to the chassis. The needle shroud in the retracted position
releases
the syringe retainer to allow for the proximal translation of the syringe
retainer with
respect to the chassis. Thus, a proximal movement of the syringe retainer that
inserts
the injection needle into the skin of the patient is prevented until the auto-
injector is
correctly placed upon the skin of the patient and the needle shroud is pushed
against
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
6
the skin surface towards the retracted position. This prevents an inadvertent
early
initiation of the injection and accidental needle stick injuries resulting
from an inaccurate
placement of the auto-injector.
According to yet another possible embodiment of the invention, the drive means
is
arranged as a single compression spring. The mechanism of the auto-injector is
arranged in a manner that a plurality of functions is executed by the single
drive means.
The injection needle is inserted into the skin of the patient, the plunger is
translated to
expel the medicament and the needle shroud is moved proximally to provide
needle
safety after the injection is completed by the action of the drive means.
Conventional
auto-injectors usually comprise a plurality of spring means to accomplish
these tasks.
The auto-injector according to the invention comprises only few parts and is
particularly
inexpensive to mass-produce. Consequently, the auto-injector is particularly
suited as a
single-use device that may be disposed after an injection has been carried
out.
According to yet another possible embodiment of the invention, a manually
actuatable
and tubular release element is slideably arranged with respect to the chassis.
Manual
actuation of the release element releases the drive means and initiates the
injection.
The tubular release element extends over a substantial length of the chassis
and may
easily be gripped by a user carrying out the injection. Alternatively, the
release element
may be arranged as a push button at a distal end of the auto-injector. The
auto-injector
is particularly intuitive to operate.
According to an alternative embodiment of the invention, the release element
is hinged
to a lateral side of the chassis. Conventional auto-injectors are commonly
activated by
actuating a push button or the like arranged at a distal end of the auto-
injector. An
inexperienced user of such a conventional auto-injector may easily mistake the
distal
end for a proximal end of the auto-injector and thus may pierce his finger
while trying to
actuate the auto-injector. The lateral arrangement of the release element is a
simple
means to prevent such accidental needle stick injuries resulting from a misuse
of the
auto-injector.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
7
According to yet another embodiment of the invention, the release element is
initially
latched to the chassis to prevent an inadvertent manual actuation releasing
the drive
means. Pushing the needle shroud against the skin of the patient moves the
needle
shroud in the retracted position. The needle shroud in the retracted position
is arranged
to unlatch the release element, so that the release element may be manually
actuated
to release the drive means. This forces the user of the auto-injector to
perform a series
of actions necessary to start the injection in the proper order to minimize
the risk of
needle stick injuries and/or an inadvertent release of the drive means
expelling the
medicament. In particular, the auto-injector first has to be properly placed
onto the skin
of the person before the injection needle is inserted by actuating the release
element.
In one possible embodiment of the invention, a resilient bushing is arranged
to engage
the coupling shroud that is biased by the drive means and coupled to the
plunger of the
pre-filled syringe. The elastic bushing is firmly attached to a distal end of
the chassis.
The coupling shroud initially latches to the bushing to prevent an inadvertent
and early
release of the drive means.
According to yet another possible embodiment of the invention, the needle
shroud is
slidable from an initial advanced position in a distal direction to a
retracted position. In
particular, the needle shroud may be slid to the retracted position by placing
the auto-
injector onto the skin of the patient receiving the injection and pressing the
needle
shroud against the skin of the patient. The needle shroud in the retracted
position
indicates the correct placement of the auto-injector. An activation of the
mechanism of
the auto-injector delivering the medicament to the patient requires the needle
shroud to
be positioned in the retracted position to ensure that the auto-injector is
properly used.
The needle shroud is slidable from the retracted position in the proximal
direction
beyond the advanced position and further to the safe position. In the safe
position, the
needle shroud surrounds the injection needle of the pre-filled syringe to
prevent
accidental needle stick injuries after the injection has been carried out.
In another possible embodiment of the invention, a rotating collar is arranged
within the
chassis of the auto-injector and axially fixed to the chassis as to prevent an
axial
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
8
translation of the rotating collar in at least the proximal direction. The
rotating collar
engages the needle shroud in a manner that forces the rotating collar to
rotate within
the chassis when the needle shroud is axially displaced, and, in particular,
translated in
the proximal direction. The rotating collar creates friction to slow down the
proximal
movement of the needle shroud that rests on the skin of the patient during the
injection.
The rotating collar acts as a dampening element that alleviates the pressure
exerted
upon the skin of the patient by the needle shroud. Thus, the risk of injuries
is reduced
and, in particular, bruises may be avoided. Furthermore, the modulus of
resilience of the
drive means driving the needle shroud may be chosen to be sufficiently large
without
having to worry about potential injury risks. Thus, the modulus of resilience
of the drive
means is adapted to reliably provide an energy supply for executing a
plurality of
actions comprising, among others, the advancing and releasing of the needle
shroud,
the displacement of the stopper to expel the medicament and the decoupling of
the
plunger from the coupling shroud.
Preferably, the rotating collar comprises a pin that engages a helical recess
formed into
the needle shroud. The engagement of the helical recess and the pin forces the
rotating
collar to rotate around the needle shroud when the needle shroud is translated
from the
advanced position to the safe position. This dampens the proximal movement of
the
needle shroud and thus reduces impact upon the skin of the patient by
generating
friction.
The auto-injector may preferably be used for subcutaneous or intra-muscular
injection,
particularly for delivering one of an analgetic, an anticoagulant, insulin, an
insulin
derivate, heparin, Lovenox, a vaccine, a growth hormone, a peptide hormone, a
protein,
antibodies and complex carbohydrates.
Further scope of applicability of the present invention will become apparent
from the
detailed description given hereinafter. However, it should be understood that
the
detailed description and specific examples, while indicating preferred
embodiments of
the invention, are given by way of illustration only, since various changes
and
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
9
modifications within the spirit and scope of the invention will become
apparent to those
skilled in the art from this detailed description.
Brief Description of the Drawings
The present invention will become more fully understood from the detailed
description
given hereinbelow and the accompanying drawings which are given by way of
illustration only, and thus, are not limitive of the present invention, and
wherein:
Figures 1A and 1B show two different sectional views of the auto-injector
before an
injection;
Figure 2 illustrates details of the auto-injector in a sectional
view;
Figures 3A and 3B show two different sectional views of the auto-injector
after an
injection stroke delivering a medicament has been carried out;
Figure 4 illustrates details of the auto-injector in a sectional
view that ensure
a complete delivery of the medication;
Figures 5A and 5B show two different sectional views of the auto-injector
after uthe
injection;
Corresponding parts are marked with the same reference symbols in all figures.
Detailed Description of Preferred Embodiments
Figures 1A and 1B show two sectional views of an essentially cylindrical auto-
injector 1,
wherein the sectional planes shown are oriented perpendicularly to each other.
The
auto-injector 1 comprises a chassis 2, a needle shroud 3, a syringe retainer 4
adapted
to mount a pre-filled syringe 5 within the chassis 2 and a coupling shroud 6
slidably
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
arranged within the chassis 2. A tubular release element 7 is in slidable
arrangement
with the cylindrical chassis 2 and may be gripped by a user performing an
injection. The
tubular release element 7 and the needle shroud 3 extend over a substantial
axial
length of the chassis 2.
5
Alternatively, the release element 7 may be arranged as a push button located
at a
distal end of the auto-injector 1.
In another alternative embodiment of the invention, the release element 7 is
laterally
10 hinged to the chassis 2 and may pivot about a hinge to activate the
injection mechanism
of the auto-injector 1.
A single drive means 8 is arranged within the chassis 2 to bias the coupling
shroud 6 in
a proximal direction P towards the skin of a patient receiving an injection.
According to one possible embodiment of the invention, the drive means 8 is
arranged
as a single, conventional compression spring.
The coupling shroud 6 is releasably coupled to a plunger 9 connected to a
stopper 10
fluid-tightly sealing a distal end of a syringe barrel 11 containing a dose of
a
medicament M. An inner cavity of the syringe barrel 11 is in fluid
communication with an
injection needle 12, so that the dose of the medicament M may be expelled
through the
injection needle 12 by displacing the stopper 10 in the proximal direction P.
A bushing 13 is firmly attached to the distal end of the chassis 2. The
bushing 13
comprises a resilient inner sleeve 13.1 with a collar 13.2 that protrudes
radially
outwards. A lug 7.1 formed to an inner surface of the release element 7 is
retained
within the inner sleeve 13.1 in a locked position L. The lug 7.1 snugly fits
into the inner
sleeve 13.1, so that a deformation and an inward deflection of the inner
sleeve 13.1 are
prevented.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
11
Furthermore, the bushing 13 acts as a counter bearing for the drive means 8 to
bias the
coupling shroud 6 in the proximal direction P.
A first clip 6.1 is formed to the coupling shroud 6 that latches to the collar
13.2 of the
bushing 13 to releasably retain the coupling shroud 6 in a first position I,
wherein the
coupling shroud 6 is located at a distal end of the chassis 2 and the drive
means 8 is
fully compressed, so that the coupling shroud 6 is strongly biased in the
proximal
direction P.
The plunger 9 extends from the syringe barrel 11 in a distal direction D and
comprises a
shoulder 9.1 with an increased diameter. The coupling shroud 6 comprises an
inwardly
protruding coupling catch 6.2 that abuts against the shoulder 9.1 so that the
plunger 9
and the coupling shroud 6 may be jointly moved in the proximal direction P by
the action
of the relaxing drive means 8. An inner surface of the chassis 2 abuts
radially against
the coupling catch 6.2 to prevent an outward deflection thereof. A
longitudinal
aperture 2.1 is formed into the chassis 2 to allow for a radial outward
deflection of the
coupling catch 6.1 at the end of an injection stroke, so that the coupling
catch 6.1 may
overcome the shoulder 9.1 to decouple the coupling shroud 6 and the plunger 9
after
the medicament M has been delivered.
The needle shroud 3 is designed to rest on the skin surface of the patient
during the
injection. Edges of the needle shroud 3 may thus be smoothed to avoid
injuries. The
needle shroud 3 is slidably arranged with the chassis 2 of the auto-injector
1, so that the
needle shroud 3 may be pushed from an advanced position PA shown in figure 1
in the
distal direction D. A biasing means 14 bears against the needle shroud 3 and
the
chassis 2 to bias the needle shroud towards the advanced position PA. The
biasing
means 14 may be arranged as a compression spring.
An intermediate section 3.1 of the needle shroud 3 may slide along the
longitudinal
aperture 2.1 when the needle shroud 3 is axially translated. The coupling
catch 6.2 may
engage the intermediate section 3.1 of the needle shroud 3 at the end of an
injection
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
12
stroke to prevent an early decoupling of the coupling collar 6 and the plunger
9. (See
Figures 2 and 4)
A ring-shaped rotating collar 15 is axially fixed to the chassis 2 in the
proximal
direction P and engages an outer surface of the needle shroud 3. The rotating
collar 15
rotates around an axis of the auto-injector 1 when the needle shroud 3 is
axially
displaced in the proximal direction P. The rotating collar 15 acts as a
dampening means
that creates friction to slow down the proximal movement of the needle shroud
3 after
the medicament M has been delivered beneath the skin of the patient. A helical
recess 3.2 is formed into an outer surface of the needle shroud 3 that
accommodates a
pin 15.1 formed to an inner surface of the rotating collar 14. When the needle
shroud 3
is translated with respect to the chassis 2 from an advanced position PA to a
safe
position PS, the pin 15.1 travels along the helical recess 3.2, so that the
rotating
collar 14 is forced to rotate within the chassis 2 around the axis of the auto-
injector 1.
Before the injection, the needle shroud 3 is mounted to the chassis 2 by
retaining
protrusions 2.2 that protrude into orifices formed into lateral sides of the
needle
shroud 3. Each orifice comprises an axial length that is dimensioned to allow
the needle
shroud 3 to be slid from the advanced position PA to a retracted position PR.
A first catch 2.3 is formed to an inner surface of the chassis 2 and protrudes
through an
opening formed into the needle shroud 3 to releasably retain the syringe
retainer 4
retaining the pre-filled syringe 5. The first catch 2.3 comprises a bevelled
ramp and is
deflectable in a radial outward direction. The first catch 2.3 latches to an
outward
protrusion 4.1 formed to the outer surface of the syringe retainer 4 when the
needle
shroud 3 is in the advanced position PA.
The needle shroud 3 abuts against the bevelled ramp of the first catch 2.3
when the
needle shroud 3 is moved from the advanced position PA in the distal direction
D,
whereby the first catch 2.3 is deflected in a radial outward direction and
disengages the
outward protrusion 4.1 from the chassis 2, so that the syringe retainer 4 may
be moved
in the proximal direction P.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
13
Before use of the auto-injector 1, second clips 2.4 on the chassis 2 latch to
the release
element 7. The second clips 2.4 block the movement of the release element 7 in
the
proximal direction P, so that a manual actuation of the release element 7 is
prevented
as long as the needle shroud 3 is in the advanced position PA.
The second clip 2.4 comprises a bevelled ramp that the needle shroud 3 engages
when
pushed from the advanced position PA in the distal direction D to the
retracted
position PR, shown in detail in figures 3A and 3B, whereby the second clip 2.4
is radial
outwardly deflected to allow for a proximal movement of the release element 7
with
respect to the chassis 2. The release element 7 may now be actuated to release
the
drive means 8.
A distal movement of the release element 7 is blocked by a second catch 2.5
latching to
an inner surface of the release element 7.
Additionally, the release element 7 is releasably retained in position before
the injection
by first and second detents 2.6, 7.2 respectively formed to an outer surface
of the
chassis 2 and an inner surface of the release element 7, wherein the first and
the
second detents 2.6, 7.2 comprise correspondingly shaped bevelled ramps facing
each
other. The first detent 2.6 may deflect radially inwards to overcome the
second
detent 7.2 when the release element 7 is pushed in proximal direction P.
Figure 2 shows details of the auto-injector 1 in a sectional view. The
intermediate
section 3.1 of the needle shroud 3 is retained in the longitudinal aperture
2.1. The
needle shroud 3 is in the advanced position PA and may slide in the distal
direction D
towards the retracted position PR, whereby the intermediate section 3.1 moves
within
the aperture 2.1 towards a distal end thereof.
In order to inject the dose of the medicament M contained in the pre-filled
syringe 5, the
user of the auto-injector 1 pushes the needle shroud 3 against the skin of the
patient to
move the needle shroud 3 distally to the retracted position PR illustrated in
figures 3A
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
14
and 3B. The needle shroud 3 moves in the distal direction D and deflects the
bevelled
ramp of the first catch 2.3 to unlatch the syringe retainer 4. Furthermore,
the needle
shroud 3 engages the bevelled ramp of the second clip 2.4 and deflects the
second clip
radial outwardly, so that the release element 7 may be manually actuated to
release the
drive means 8.
The release means 7 is pushed in the proximal direction P to an unlocked
position U,
whereby the lug 7.1 disengages the collar 13.2 of the bushing 13. The inner
sleeve 13.1
may thus be deformed to release the first clips 6.1 and release the coupling
shroud 6
and the drive means 8. Detents 2.6 and 7.2 offer a degree of resistance to the
proximal
movement of release means 7 as their ramped faces move past each other, This
provides a differentiation in the resistance felt by the user between pushing
the needle
shroud from the advanced to the retracted position, and activating the
injection process,
thereby improving the experience of the user in using the auto-injector.
Upon release of the drive means 8, the coupling shroud 6 is urged in the
proximal
direction P. The single and fully charged drive means 8 drives the coupling
shroud 6
and the plunger 9 coupled thereto in the proximal direction P. The coupling
shroud 6
first pushes the syringe retainer 4 in the proximal direction P until the
injection needle 12
of the pre-filled syringe 5 retained within the syringe retainer 4 punctures
the skin of the
patient. When the injection needle 12 is inserted into the skin of the
patient, a third
clip 2.7 formed into a lateral side of the chassis 2 latches to the outward
protrusion 4.1
of the syringe retainer 4, as illustrated in figure 3B, as to prevent a
subsequent axial
translation of the syringe retainer 4 with respect to the chassis 2.
The protrusion 4.1 abuts against a rib 2.9. in the chassis 2 defining the
injection depth of
the needle 12. The third clip 2.7 is arranged to hold the protrusion 4.1 in
place after it
has reached the full injection depth. When the syringe retainer 4 carrying the
pre-filled
syringe 5 is clipped to the chassis 2 by the third clips 2.7, the injection
needle 12
protrudes from the needle shroud 3 in the proximal direction P and penetrates
the skin
surface of the patient at the desired injection depth.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
The coupling shroud 6 is moved by the drive means 8 in the proximal direction
P into a
second position II illustrated in figure 3A. As the syringe retainer 4 and
syringe 5 can
move no further in the proximal direction, plunger 9 and stopper 10 are forced
further
into the bore of syringe barrel 11, displacing medicament M through the needle
12. The
5 coupling shroud 6 in the second position II engages a bevelled ramp of
the distal
retaining protrusion 2.2. The retaining protrusions 2.2 are resiliently
supported and may
be deflected in the radial outward direction. The coupling shroud 6 engaging
the distal
retaining protrusion 2.2 pushes the section of the chassis 2 supporting the
retaining
protrusions 2.2 radially outwards, whereby the needle shroud 3 is released
from the
10 chassis 2 and may move towards the advanced position PA and further to
the safe
position PS upon removal of the auto-injector 1 from the injection site.
As illustrated in detail in figure 4, the intermediate section 3.1 of the
needle shroud 3 is
located near the distal end of the longitudinal aperture 2.1 as long as the
needle
15 shroud 3 is retained in the retracted position PR by pushing the needle
shroud 3 against
the skin of the patient. In a second position II, the coupling catch 6.2 bears
against the
intermediate section 3.1 in a radial outward direction. An outward deflection
of the
coupling catch 6.2 releasing the coupling between the plunger 9 and the
coupling
shroud 6 is thus prevented whilst needle shroud 3 is in the retracted position
PR. The
user holds the auto-injector against the skin for a sufficient period of time
to ensure the
plunger 9 is fully depressed in the syringe barrel 11 and the dose of the
medicament M
is completely expelled.
The auto-injector 1 is then removed from the injection site, whereby the
biasing
means 14 moves the needle shroud 3 and in particular the intermediate section
3.1 of
the needle shroud 3 in the proximal direction P. The coupling catch 6.2 may
now
protrude into the aperture 2.1 allowing for an outward deflection of the
coupling
catch 6.2 decoupling the plunger 9 and the coupling shroud 6 due to the ramped
engagement of the shoulder 9.1 and the coupling catch 6.2.
As the coupling catch 6.2 is forced radially outwards after the intermediate
section 3.1
has moved in the proximal direction P, the coupling catch 6.2 will move out
just behind
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
16
the intermediate section 3.1 and as it is now released from the plunger 9 can
push the
intermediate section 3.1 and hence the needle shroud 3 in the proximal
direction P. The
biased coupling shroud 6 bears against the needle shroud 3 and moves the
needle
shroud 3 from the retracted position PR to the safe position PS shown in
figures 5A
and 5B. The rotating collar 15 with the pin 15.1 engaging the helical recess
3.2 of the
needle shroud 3 rotates while the needle shroud 3 is moved in the proximal
direction P.
The proximal movement of the needle shroud 3 is thus slowed down and damped.
The
rotating collar 15 acts as a damping element that reduces impact upon the skin
of the
patient by the needle shield 3 on translation into the safe position PS.
Figure 5A and 5B show two different sectional views of the auto-injector 1
after the
injection is completed and the auto-injector 1 is removed from the injection
site. The
sectional plane shown in figure 5A extends perpendicularly to the one shown in
figure 5B. The injection needle 12 is surrounded by the needle shroud 3 which
protrudes beyond the tip of needle 12 in the safe position PS sufficiently far
to avoid
accidental needle stick injuries after the injection. The needle shroud 3 is
permanently
locked in the safe position PS by fourth clips 2.8 on the chassis 2 that latch
to the
needle shroud 3 after the injection is completed.
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
17
List of References
1 auto-injector
2 chassis
2.1 aperture
2.2 retaining protrusion
2.3 first catch
2.4 second clip
2.5 second catch
2.6 second detent
2.7 third clip
2.8 fourth clip
2.9 rib
3 needle shroud
3.1 intermediate section
3.2 helical recess
4 syringe retainer
4.1 outward protrusion
5 pre-filled syringe
6 coupling shroud
6.1 first clip
6.2 coupling catch
7 release element
7.1 lug
7.2 second detent
8 drive means
9 plunger
9.1 shoulder
10 stopper
CA 02821631 2013-06-13
WO 2012/085023
PCT/EP2011/073504
18
11 syringe barrel
12 injection needle
13 bushing
13.1 inner sleeve
13.2 collar
14 biasing means
rotating collar
15.1 pin
= medicament
10 PA advanced position
PR retracted position
PS safe position
first position
11 second position
15 L locked position
= ulocked position
= distal direction
= proximal direction
